Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/10/2012 | CA2304159C Methods of evaluating transplant rejection |
07/10/2012 | CA2268363C An indexed library of cells containing genomic modifications and methods of making and utilizing the same |
07/10/2012 | CA2254717C Biosynthesis method enabling the preparation of cobalamins |
07/10/2012 | CA2222601C Plasmid for delivery of nucleic acids to cells and methods of use |
07/10/2012 | CA2211324C Recombinant human alpha-fetoprotein and uses thereof |
07/10/2012 | CA2203569C Nucleotide sequence encoding the enzyme i-scei and the uses thereof |
07/10/2012 | CA2194172C Neurturin and related growth factors |
07/10/2012 | CA2132306C Selection methods |
07/05/2012 | WO2012092596A2 Nucleic acid molecules that target the rho1 small gtp-binding protein and confer resistance to coleopteran pests |
07/05/2012 | WO2012092580A2 Nucleic acid molecules that target the vacuolar atpase h subunit and confer resistance to coleopteran pests |
07/05/2012 | WO2012092577A1 Intercellular transfer of organelles in plants for horizontal transfer of dna expressing proteins |
07/05/2012 | WO2012092573A2 Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests |
07/05/2012 | WO2012092544A2 Nucleic acid molecules that confer resistance to coleopteran pests |
07/05/2012 | WO2012092485A1 Enhancement of placental stem cell potency using modulatory rna molecules |
07/05/2012 | WO2012092382A2 Role of microrna in t cell immune response |
07/05/2012 | WO2012092376A2 Comprehensive monoclonal antibody generation |
07/05/2012 | WO2012092374A2 Express humanization of antibodies |
07/05/2012 | WO2012092327A2 Methods to determine zygosity in a bulked sample |
07/05/2012 | WO2012092323A1 Cell surface display using pdz domains |
07/05/2012 | WO2012092106A1 Novel bacillus thuringiensis gene with lepidopteran activity |
07/05/2012 | WO2012091812A1 Use of saccharomyces cerevisiae suc2 gene in yarrowia lipolytica for sucrose utilization |
07/05/2012 | WO2012091590A1 A recombinant cytotoxin as well as a method of producing it |
07/05/2012 | WO2012091496A2 siRNA FOR INHIBITION OF Hif1α EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME |
07/05/2012 | WO2012091165A1 Method for utilizing monoterpene glycosyltransferase |
07/05/2012 | WO2012091138A1 Diagnostic drug and diagnostic method for alzheimer's disease |
07/05/2012 | WO2012091136A1 Expression vector, method for producing carrier using same, and use of same |
07/05/2012 | WO2012091110A1 Modified tamavidin |
07/05/2012 | WO2012091101A1 Multi-recognition-type bioluminescent probe system |
07/05/2012 | WO2012091091A1 Compound, nucleic acid, method for producing nucleic acid, and kit for producing nucleic acid |
07/05/2012 | WO2012090978A1 Transformant of coryneform bacterium, and method for producing aniline using same |
07/05/2012 | WO2012090950A1 Plant having improved resistivity or sensitivity to 4-hppd inhibitor |
07/05/2012 | WO2012090939A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells |
07/05/2012 | WO2012090895A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
07/05/2012 | WO2012090789A1 Polypeptide for distinguishing silicon oxide from silicon nitride, and use thereof |
07/05/2012 | WO2012090705A1 Method for detecting methylated cytosine |
07/05/2012 | WO2012090500A1 Dna involved in gene expression regulation in photosynthetic tissue |
07/05/2012 | WO2012090499A1 Mature leaf - specific promoter |
07/05/2012 | WO2012090479A1 Mcm7 as a target gene for cancer therapy and diagnosis |
07/05/2012 | WO2012090183A1 Method for immobilising nucleic ligands |
07/05/2012 | WO2012089800A1 Immunostimulatory oligodeoxynucleotides |
07/05/2012 | WO2012089736A1 Sirna against cbl-b and optionally il2 und il12 for use in the treatment of cancer |
07/05/2012 | WO2012089631A1 Luminescent composition as biomarker in a bird's egg, corresponding device and method |
07/05/2012 | WO2012089602A1 Small molecule conjugates for intracellular delivery of biologically active compounds |
07/05/2012 | WO2012089352A1 Small molecule conjugates for intracellular delivery of nucleic acids |
07/05/2012 | WO2012089348A1 Means for generating adenoviral vectors for cloning large nucleic acids |
07/05/2012 | WO2012089342A1 Production of high mannose glycosylated proteins stored in the plastid of microalgae |
07/05/2012 | WO2012089164A1 Functional construction of secb-mediated post-translational targeting pathway and use thereof |
07/05/2012 | WO2012088739A1 Method for preparing fusion protein of mycobacterium tuberculosis antigens and uses thereof |
07/05/2012 | WO2012088608A1 Compositions comprising natriuretic peptides and methods of use thereof |
07/05/2012 | WO2012065027A3 Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases |
07/05/2012 | WO2012064967A3 Cancer cell-derived receptor activator of the nf-kb ligand drives bone and soft tissue metastases |
07/05/2012 | WO2012061225A3 Gardnerella vaginalis assay |
07/05/2012 | WO2012058268A3 Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1 |
07/05/2012 | WO2012055573A8 Use of hepcidin binding nucleic acids for depletion of hepcidin from the body |
07/05/2012 | WO2012054723A3 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
07/05/2012 | WO2012050975A3 Novel circular mammalian rna molecules and uses thereof |
07/05/2012 | WO2012047899A3 Novel dna hypermethylation diagnostic biomarkers for colorectal cancer |
07/05/2012 | WO2012045022A3 Metabolic engineering of clostridium tyrobutyricum for butanol production |
07/05/2012 | WO2012037232A3 Compositions, methods and kits for detecting and treating alzheimer's disease |
07/05/2012 | WO2012033524A3 Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme |
07/05/2012 | WO2012031021A3 Improved detection of nucleic acid sequences adjacent to repeated sequences |
07/05/2012 | WO2012030983A3 Variability single nucleotide polymorphisms linking stochastic epigenetic variation and common disease |
07/05/2012 | WO2012027209A3 Defensin variants and methods of use |
07/05/2012 | WO2012024526A3 Conjugates, particles, compositions, and related methods |
07/05/2012 | WO2012024350A3 Anti-cancer adenoviruses |
07/05/2012 | WO2012021730A3 Respiratory syncytial virus (rsv) vaccine |
07/05/2012 | WO2012018813A3 Modified infectious laryngotracheitis virus (iltv) and uses thereof |
07/05/2012 | WO2012015938A3 Obligate heterodimer variants of foki cleavage domain |
07/05/2012 | WO2012009402A3 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
07/05/2012 | WO2012003129A3 Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host |
07/05/2012 | WO2011159713A3 Compositions and methods for gene expression and chromatin profiling of individual cell types within a tissue |
07/05/2012 | WO2011155973A8 Modified renilla luciferase nucleic acids and methods of use |
07/05/2012 | WO2011110953A3 Polyepitope constructs and methods for their preparation and use |
07/05/2012 | WO2011084366A3 Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions |
07/05/2012 | WO2011079314A8 Compositions and methods for the increased production of isoprene and other products with 6 - phosphogluconolactonase (pgl) |
07/05/2012 | WO2008141174A9 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof |
07/05/2012 | US20120174264 Uses of Yerba Santa |
07/05/2012 | US20120174263 Production of viral capsids |
07/05/2012 | US20120174262 Methods and compositions for a soybean in-planta transient expression system |
07/05/2012 | US20120174261 Plant seeds with alterred storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase |
07/05/2012 | US20120174260 Nucleic acid molecules that target the rho1 small gtp-binding protein and confer resistance to coleopteran pests |
07/05/2012 | US20120174259 Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests |
07/05/2012 | US20120174258 Nucleic acid molecules that confer resistance to coleopteran pests |
07/05/2012 | US20120174257 Use of gene involved in accumulation of cadmium in plants |
07/05/2012 | US20120174256 Recombinant dna molecule encoding 5' utr capable of preventing inhibition of translation under environmental stresses |
07/05/2012 | US20120174255 Gene and Variations Associate with BM1 Phenotype, Molecular Markers, and their Use |
07/05/2012 | US20120174248 Tomato hybrid ps02326502 |
07/05/2012 | US20120174247 Tomato hybrid ps02450650 and parent lines thereof |
07/05/2012 | US20120174245 Transposition of maize ac/ds elements in vertebrates |
07/05/2012 | US20120174243 SOGA Polynucleotides and Polypeptides and Uses Thereof |
07/05/2012 | US20120174242 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
07/05/2012 | US20120172631 Phosphatidyl oligoglycerols |
07/05/2012 | US20120172577 Methods of producing proteins having triple-helix structure |
07/05/2012 | US20120172576 Method and marker for simple transformation and selection of recombinant protists |
07/05/2012 | US20120172420 Method for Modulating Responsiveness to Steroids |
07/05/2012 | US20120172419 Reagents and methods for modulating cone photoreceptor activity |
07/05/2012 | US20120172418 Aslv vector system |
07/05/2012 | US20120172415 Exon Skipping Therapy for Functional Amelioration of Semifunctional Dystrophin in Becker and Duchenne Muscular Dystrophy |
07/05/2012 | US20120172413 Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same |
07/05/2012 | US20120172301 Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ace2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling |